The University of Liverpool has published this notice through Delta eSourcing
Notice Summary |
---|
Title: | GB-Liverpool: GLP Toxicology evaluation of Long-Acting Injectable (LAI) products for LTBI prevention and HCV cure |
Notice type: | Competitive Contract Notice |
Authority: | The University of Liverpool |
Nature of contract: | Not applicable |
Procedure: | Not applicable |
Short Description: | The University of Liverpool, through its LONGEVITY project funded by Unitaid, is implementing product development and commercialization of Long-Acting Injectable (LAI) formulations for malaria and tuberculosis prevention, and a hepatitis C virus cure for Low- and Middle-Income Countries (LMIC’s). The University of Liverpool was awarded 32 million US dollars in early 2020 from Unitaid (https://unitaid.org/) as part of the 40 million US dollar project to fund these activities to commercialisation.https://unitaid.org/news-blog/unitaid-invests-in-long-acting-medicines-to-simplify-treatment-and-prevention-for-hiv-tb-malaria-and-hcv/#en https://www.liverpool.ac.uk/chemistry/news/articles/24m-boost-for-revolutionary-long-acting-medicine-research/ The TB and HCV products are reaching the end of proof-of-concept studies and the University of Liverpool is seeking quotations for provision of GLP toxicology services to support product clinical stage progress. Full outline of study requirements available from the University of Liverpool’s tendering website (details included in other information section below) |
Published: | 01/03/2024 16:34 |
View Full Notice
1. Title: GB-Liverpool: GLP Toxicology evaluation of Long-Acting Injectable (LAI) products for LTBI prevention and HCV cure
2. Awarding Authority:
University of Liverpool
Procurement, Foundation Building, 765 Brownlow Hill, Liverpool, L69 7ZX, United Kingdom
Tel. 01517942157, Email: bickera@liverpool.ac.uk, URL: https://in-tendhost.co.uk/liverpooluni/aspx/Home
Attn: Ann Bickerstaffe
3. Contract Type: Services
Sub Type: Other services.
4. Description: Research laboratory services. The University of Liverpool, through its LONGEVITY project funded by Unitaid, is implementing product development and commercialization of Long-Acting Injectable (LAI) formulations for malaria and tuberculosis prevention, and a hepatitis C virus cure for Low- and Middle-Income Countries (LMIC’s). The University of Liverpool was awarded 32 million US dollars in early 2020 from Unitaid (https://unitaid.org/) as part of the 40 million US dollar project to fund these activities to commercialisation.https://unitaid.org/news-blog/unitaid-invests-in-long-acting-medicines-to-simplify-treatment-and-prevention-for-hiv-tb-malaria-and-hcv/#en
https://www.liverpool.ac.uk/chemistry/news/articles/24m-boost-for-revolutionary-long-acting-medicine-research/ The TB and HCV products are reaching the end of proof-of-concept studies and the University of Liverpool is seeking quotations for provision of GLP toxicology services to support product clinical stage progress. Full outline of study requirements available from the University of Liverpool’s tendering website (details included in other information section below)
5. CPV Codes:
73111000 - Research laboratory services.
6. NUTS Codes :
UKD72 - Liverpool
7. Main Site or Location of Works, Main Place of Delivery or Main Place of Performance: Liverpool,
8. Reference Attributed by the Awarding Authority: 2024/07/AB
9. Estimated Value of Requirement: Category H: 100K to 500K
Currency: GBP
10. Deadline for Expression of Interest: 01/04/2024 12:00:00
11. Address to which they must be sent:
Not Provided
12. Other Information:
Other Information: THE TENDER DOCUMENTATION IS LOCATED ON THE FOLLOWING WEB SITE https://in-tendhost.co.uk/liverpooluni Select ‘Tenders’ from the top menu bar, select ‘current’, then click ‘view details’ button. To gain full access to this website and tender documentation you need to log in using your existing registration details or click the ‘Register’ button if you have not registered before. When registering PLEASE make sure the ‘publish e-mail address’ field is completed accurately as this will receive all automated correspondence. Please return your tender as detailed in the document. The submitted tender will be evaluated in accordance with the criteria stated in the invitation to tender documents and companies may be invited to attend for interview as part of the process. All dates, time periods and quantities indicated in this Notice are provisional only and the university reserves the right to change the same if circumstances so dictate. The University reserves the right not to enter in to any contract pursuant to this Notice and to withdraw from this procurement exercise at any time. The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=845905974
TKR-202431-PRO-25389179
Suitable for VCO: No
Procedure Type:OPEN
Period of Work Start date: 01/10/2024
Period of Work End date: 01/02/2025
Is this a Framework Agreement?: no
View any Notice Addenda
View Award Notice
Associated Parent Notice
CompetitiveContractNotice - GB-Liverpool: GLP Toxicology evaluation of Long-Acting Injectable (LAI) products for LTBI prevention and HCV cure
1. Title: GB-Liverpool: GLP Toxicology evaluation of Long-Acting Injectable (LAI) products for LTBI prevention and HCV cure
2. Awarding Authority:
University of Liverpool
Procurement, Foundation Building, 765 Brownlow Hill, Liverpool, L69 7ZX, United Kingdom
Tel. 01517942157, Email: bickera@liverpool.ac.uk, URL: https://in-tendhost.co.uk/liverpooluni/aspx/Home
Attn: Ann Bickerstaffe
3. Contract Type: Services
Sub Type: Other services.
4. Description: Research laboratory services. GLP toxicology services
5. CPV Codes:
73111000 - Research laboratory services.
6. NUTS Codes :
UKD72 - Liverpool
7. Main Site or Location of Works, Main Place of Delivery or Main Place of Performance: Liverpool,
8. Reference Attributed by the Awarding Authority: 2024/07/AB
9. Awarded to:
Charles River Laboratories Inc.
Elphinstone Research Centre, Tranent, EH33 2NE, United Kingdom
Tel. 01875614545
Attn: Diana Pirie
Value Cost: 450,000
Is Awardee likely to subcontract?: No Awarded to SME?: No
10. Date of Contract Award: 20/08/2024
11. Number of Tenders Received: 3
12. Other Information:
Other Information: To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=883946840
TKR-2024821-PRO-27452849
Suitable for VCO: No
Procedure Type:OPEN
Period of Work Start date: 01/10/2024
Period of Work End date: 01/02/2025